chevron_leftBack
As of 24 April 2025, InnoCan Pharma Corp. has a market cap of $38.01M USD, ranking #26327 globally and #816 in Canada. It ranks #2662 in the Healthcare sector, and #576 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$38.01MUSD
52.64M CAD
Enterprise Value
$34.67MUSD
48.11M CAD
Revenue (TTM)
$30.58MUSD
42.36M CAD
EBITDA (TTM)
-$1.26MUSD
-1.74M CAD
Net Income (TTM)
-$1.91MUSD
-2.64M CAD
EBITDA Margin
-4.1%
Profit Margin
-6.2%
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Iris Bincovich
open_in_new
Founded
2018
Website
innocanpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.8% | 0% | -10% | -2.7% | -18% | -33% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
INNO
InnoCan Pharma Corp Ordinary Shares
ISIN: CA45783P1027
Shares Out.:
Shares Outstanding:
290.116M1
Shares Float:
221.942M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1800 CAD | |
|
INNPF
InnoCan Pharma Corp Ordinary Shares
ISIN: CA45783P1027
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1400 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About InnoCan Pharma Corp.
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments, Pharmaceuticals and Consumer Wellness. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management. The company is also involved in the development and sale of CBD-integrated pharmaceuticals and topical products. In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company offers its products under the Innocan Pharma, R&G Relief & Go, Shir, Synony, and Add On trade names. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
